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Ilse M. J. Kant6, Simone J. T. van Montfort6, Ellen Aarts6, Jochen Kruppa5, Arjen Slooter6, Georg Winterer7,8, 
Tobias Pischon1,8,9† and Claudia Spies2†
Abstract 
Objective: Studies of postoperative cognitive dysfunction (POCD) rely on repeat neuropsychological testing. The 
stability of the applied instruments, which are affected by natural variability in performance and measurement 
imprecision, is often unclear. We determined the stability of a neuropsychological test battery using a sample of older 
adults from the general population. Forty-five participants aged 65 to 89 years performed six computerized and non-
computerized neuropsychological tests at baseline and again at 7 day and 3 months follow-up sessions. Mean scores 
on each test were compared across time points using repeated measures analyses of variance (ANOVA) with pairwise 
comparison. Two-way mixed effects, absolute agreement analyses of variance intra-class correlation coefficients (ICC) 
determined test–retest reliability.
Results: All tests had moderate to excellent test–retest reliability during 7-day (ICC range 0.63 to 0.94; all p < 0.01) 
and 3-month intervals (ICC range 0.60 to 0.92; all p < 0.01) though confidence intervals of ICC estimates were large 
throughout. Practice effects apparent at 7 days eased off by 3 months. No substantial differences between comput-
erized and non-computerized tests were observed. We conclude that the present six-test neuropsychological test 
battery is appropriate for use in POCD research though small sample size of our study needs to be recognized as a 
limitation.
Trial registration ClinicalTrials.gov Identifier NCT02265263 (15th October 2014)
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Introduction
Postoperative cognitive dysfunction (POCD) is a neu-
rocognitive disorder (NCD) that affects around 10 to 
38% of older adults during the first few months after 
surgery [1] but despite attempts at consensus [2] it is 
poorly defined. As of today POCD remains a research 
diagnosis that is dependent on formal, repeat neu-
ropsychological testing rather than clinical diagnosis. 
Distinction of a clinically relevant cognitive change due 
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to surgery from natural variability and measurement 
error is imperative in these settings. Practice effects, 
for instance, lead to improved performance (or a milder 
decline) due to familiarity with test stimuli and test-
ing situation [3]. To this end, rather than relying on 
raw cognitive change [4], surgical patients’ scores are 
typically converted using ‘reliable change index’ (RCI) 
algorithms. These algorithms compare patients’ pre- 
to post-surgery change to that of a non-surgical age-
matched control group [5].
There is substantial variation in the number and types 
of neuropsychological tests that have been used in 
POCD research, however [6]. This hampers compara-
bility between studies and may account for inconsistent 
results in POCD incidence [7] and epidemiology [8]. Spe-
cifically, a priori evaluation of their psychometric prop-
erties including their stability over time as measured by 
test–retest reliability in relevant control samples is rarely 
considered in test selection. One previous study assessed 
the neuropsychological test battery of the International 
Study of Post‐Operative Cognitive Dysfunction cohort 
(ISPOCD), one of the most influential studies on POCD, 
and found that test–retest reliability was unsatisfactory 
for several of its subtests [9] but these types of findings 
have generally been overlooked.
POCD research has also undergone a shift from con-
ventional to computerized testing (e.g., [10]). Yet studies 
of POCD focus on older adults who are prone to com-
puter anxiety [11] which may affect computerized test 
performance [12, 13]. Even in younger adults, one study 
found only modest correlations of computerized perfor-
mance with conventional, non-computerized tests [14] 
and in a study of older surgical patients, POCD defined 
from computerized tests showed only moderate agree-
ment with POCD defined from conventional tests [15].
In sum, what is needed is a strategic evaluation of 
computerized and non-computerized neuropsychologi-
cal tests that are commonly used in POCD research in 
terms of their stability over time in individuals who do 
not undergo surgery and thus are not expected to present 
with cognitive decline during a brief follow-up period. 
This will help investigators refine their choice of neu-
ropsychological tests and understand methodological 
limitations when reporting on POCD.
Here, we determined the stability of a set of six 
neuropsychological tests (four computerized; two 
non-computerized) in a sample of older community-
dwelling non-surgical controls recruited for the Bio-
marker Development for Postoperative Cognitive 
Impairment in the Elderly (BioCog) study [16]. Addi-
tionally, to help clinicians gauge whether a patient’s 
change in test performance likely reflects a clini-
cally relevant change, we calculated the ‘smallest real 
difference’ as the smallest within-person change that 
can be interpreted as a ‘real’ change exceeding natural 
variability [17].
Main text
Study design
We recruited a sample of older adults at outpatient clin-
ics, primary care facilities, care homes and at public talks 
in Berlin, Germany, and Utrecht, the Netherlands, to 
serve as non-surgical control participants for the BioCog 
study [16]. Participants were eligible to participate if they 
were ≥ 65  years old, had not undergone surgery during 
the past 6 months, and were not scheduled for surgery 
within the next 3 months. Participants were excluded if 
they scored ≤ 24 on the Mini Mental State Examination 
(MMSE) [18], had a diagnosed neuropsychiatric disorder, 
reported regular intake of psychotropic medication or 
had severe visual or auditory impairment.
Neuropsychological assessment
Six neuropsychological tests with a total of eight outcome 
measures were administered once at enrolment (T0) and 
again in identical form at 7 days (T1), and 3 months (T2) 
(Table  1) [19]. Four tests were part of the Cambridge 
Neuropsychological Test Automated Battery (CANTAB; 
CANTAB Research Suite, Cambridge Cognition Ltd., 
UK) and were performed on touch-screen electronic 
devices with a press pad. The Paired Associates Learn-
ing (PAL) test of visual memory involved locating a target 
pattern among a set of potential boxes. Outcome meas-
ure was the ‘first trial memory score’. The Verbal Recog-
nition Memory (VRM) test of verbal memory involved 
sequential presentation of 12 target words, followed by 
free immediate recall and delayed recognition from a 
list of 24 words after a 20-min interval. For Spatial Span 
(SSP), participants were to repeat an increasingly long 
sequence of highlighted boxes on the screen through tap-
ping. The test assessed spatial working memory and the 
number of boxes that participants could track within 
three attempts at each level (‘spatial span’) served as out-
come. The Simple Reaction Time (SRT) test of process-
ing speed involved pressing the press pad in response to 
a stimulus. Outcome was mean reaction time across 100 
trials. Additionally, for Grooved Pegboard (GP) test of 
manual dexterity, participants placed 25 pegs into holes 
on a board using their dominant hand. For Trail-Making 
Test-A (TMT-A) as a measure of processing speed, par-
ticipants connected dots in ascending order (1–2–3–
4…). TMT-B involved alternating between letters and 
numbers (A–1–B–2–C–3…) and tested executive func-
tion and processing speed.
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Data analysis
We included only participants who attended all three 
testing sessions for our main analysis (n = 45) as we 
deemed this type of setting most relevant to POCD 
research. Patients are typically tested before surgery, 
again upon discharge and then re-attend the clinic for 
a follow-up several months thereafter. Analyses com-
paring baseline (T0) with 3-month follow-up (T2) 
were repeated post-hoc for participants who had only 
attended T0 and T2 (n = 57; see Additional file 1). Data 
on either SRT or GP were missing at T1 for one par-
ticipant, respectively. Data on TMT-B were missing 
on T2 for one participant. These participants were not 
excluded.
First, mean scores on each test were compared across 
time points using repeated measures analyses of vari-
ance (ANOVA) with pairwise comparison between 
time points T0 to T1 and T0 to T2. We used un-trans-
formed data for all analyses.
We determined relative consistency of scores over time 
between T0 and T1, and between T0 and T2, by calculat-
ing analyses of variance intraclass coefficient (ICC) esti-
mates and their 95% confidence intervals. We report on 
a mean of multiple measurements, absolute-agreement, 
2-way mixed-effects model [20, 21] based on the fact that 
this was a test–retest (rather than inter-rater) setting and 
we wished to generalize our results to a setting where 
patients are tested on multiple occasions [20].
ICC values below 0.5 indicate poor reliability, and 
0.5 to 0.75 indicate moderate reliability. Values greater 
than 0.75 suggest good reliability, and above 0.90 are 
considered excellent [20].
Finally, we calculated the ‘smallest real difference’ 
(SRD) [17]. The formula estimates the range of chance 
variation using the standard error of measurement (SEM) 
derived from the standard deviation at T0 (SD) and ICC 
to derive the standard error of difference  (Sdiff) [22].
ANOVA and ICC analyses were performed using SPSS 
(Version 23, SPSS, Chicago, Illinois).
Results
Forty-five participants (n = 18 from Berlin; n = 27 from 
Utrecht) attended all three testing sessions (Fig. 1). Par-
ticipants were between 65 and 89 years old and 53.3% 
were male (Additional file l: Table  S1). Educational 
level was relatively high with 38.1% being university-
educated. The time between baseline (T0) and 7  day 
follow-up (T1) ranged from 2 to 18  days (median 7; 
interquartile range 6–9  days) and between baseline 
(T0) and 3-month follow-up (T2) ranged from 82 to 
164 days (median 105; interquartile range 91–119 days).
There was a statistically significant effect of time point 
on performance on PAL, VRM free recall and recogni-
tion, and on TMT-B (Table  2). Pairwise comparison 
determined that performance on PAL, VRM free recall 
and TMT-B significantly improved between T0 and T1 
(7-day interval; Table 2). For instance, participants were 
on average 11 s faster on the TMT-B on the second test-
ing occasion compared with the first. Scores on VRM 
recognition significantly declined and performance on 
SRT, SSP, GP and TMT-A was unchanged during this 
time interval. Between T0 and T2 (3-month interval), 
performance only improved on TMT-B. Mean perfor-
mance on all of the remaining tests did not significantly 
change between T0 and T2 (Table 2).
ICC estimates indicated moderate to excellent reli-
ability for each of the tests (Table  2). Relatively lowest 
reliability was observed for SSP (T0 to T1, ICC 0.63; T0 
(1)SEM = SD ×
√
1− ICC
(2)Sdiff =
√
2× [SEM]2
(3)SRD = Sdiff × 1.96
Table 1 Summary of neuropsychological tests
CANTAB Cambridge Neuropsychological Test Automated Battery
Test interface Test Cognitive domain
Computerized 
(CANTAB)
Paired Associates Learning (PAL) Visual memory
Verbal recognition memory 
(VRM)—immediate free recall/
delayed recognition
Verbal memory
Simple reaction time (SRT) Processing speed
Spatial span (SSP) Spatial memory
Non-comput-
erized
Grooved Pegboard (GP) Manual dexterity
Trail-Making-A (TMT-A) Processing speed
Trail-Making-B (TMT-B) Processing speed, 
executive function
Cognive tesng
at baseline
n=114
n=45
Cognive tesng
at both 7 days and
3 months follow up
n=57
Cognive tesng
at baseline and
3 months only
Parcipants tested at 
3 months follow up
Loss to
follow up (n=12)*
n=102
Fig. 1 Study flow chart. *Cognitively tested at baseline (n = 5) or at 
baseline and 7 days follow up (n = 7) only
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to T2, ICC 0.60). GP stood out with excellent reliability 
(ICC > 0.90) at both time intervals. Confidence intervals 
of ICC for GP between T0 and T1 did not overlap with 
any of the remaining tests except SRT indicating a statis-
tically significantly higher ICC for GP than all other tests 
except SRT. ICC between T0 and T2 was also higher for 
GP than for VRM free recall, SRT and SSP.
‘Smallest real difference’ (SRD) scores are shown for 
each of the tests in Table 2. For instance, we found that a 
166 ms increase on SRT during 3-month interval exceed 
natural variation and thus can be considered a relevant 
decline in function.
Post-hoc analysis of participants who had only attended 
two testing sessions (n = 57) revealed practice effects 
between T0 and T2 that were similar to those of the main 
analysis sample (n = 45) for T0 to T1 though improve-
ment was seen on different tests (Additional file  1: 
Table S2). In terms of ICC estimates, GP (ICC > 0.90) and 
TMT-B (ICC 0.88) stood out with excellent and good 
test–retest reliabilities respectively.
Discussion
We set out to assess the stability of the BioCog neu-
ropsychological test battery in a sample of older adults 
and found tests to have moderate to excellent test–retest 
reliability throughout. Practice effects for several tests at 
7 days appeared to ease off by 3-month follow-up, despite 
the fact that at 3  months, participants benefited from 
having already been exposed to testing material and situ-
ation twice. GP stood out with excellent test–retest reli-
ability throughout. However, GP relies heavily on motor 
function and hand–eye coordination [23], and so we do 
not recommend it as a sole indicator of neurocognitive 
functioning for research purposes.
Our neurocognitive test battery consisted both of tra-
ditional non-computerized and of computerized tests. 
Computerized testing comes with a number of advan-
tages such as immunity to tester effects or transcribing 
errors. These advantages might not outweigh methodo-
logical difficulties that apply to older adults who may be 
affected by computer anxiety [11–13], however. Here, in 
line with a previous study of CANTAB [24], test–retest 
reliability of computerized tests was moderate to good. 
We found no evidence of differences in test–retest reli-
ability between the computerized tests and the non-
computerized tests. Thus computerized tests were overall 
subject to no greater intra-individual variability com-
pared with traditional tests.
For each neurocognitive test, we provided the ‘small-
est real difference’ (SRD) [17, 25] to help clinicians deter-
mine whether a change in scores of a patient is likely of 
concern. Yet it should be noted that SRD values apply to 
the present sample and follow-up period only.
Future studies are advised to scrutinize the psychomet-
ric properties of neuropsychological tests prior to their 
application. Based on our results, we see no problem with 
the use of computerized tests such as CANTAB in older 
adults. We suggest that studies (especially those defin-
ing POCD from raw change [4, 6]) consider skipping the 
respective briefest follow-up session and instead focus 
their efforts on subsequent follow-ups that may be less 
affected by practice.
Limitations
Strengths of our analysis include combination of com-
puterized with non-computerized format. However, our 
sample size was small as evidenced in large confidence 
intervals. For instance, Simple Reaction Time showed 
‘moderate’ test–retest reliability during 3-month inter-
val, but 95% confidence intervals stretched from ‘poor 
reliability’ to ‘good reliability’. Follow-up periods varied 
between participants and their relatively high educational 
status limits the generalizability of our findings. Finally, 
readers should note that a stricter cut-off for acceptable 
reliability (e.g., ICC > 0.8) should be preferred if neu-
ropsychological testing is applied in a clinical rather than 
a research setting such as our own.
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